Tessaro Hospitals runs 3,000 beds at 62% occupancy and earns an average of Rs 50,000 per occupied bed-day. Your structured idea is that occupancy rises to 72% in two years as new wings mature, with 50% of incremental revenue flowing to EBITDA. Set out the thesis, the catalyst, the numbers and the main risk.

Ten points of occupancy add about Rs 548 crore of revenue and Rs 274 crore of EBITDA, a 37% rise, and that is the whole thesis. The catalyst is the quarterly occupancy figure as the new wings fill. At an unchanged 20x, equity value would rise about 39%. The main risk is price, not volume: if new beds fill with lower-paying patients and ARPOB slips 5%, two thirds of the gain disappears.

Think of a cinema. The screen, the staff and the air conditioning cost the same whether 60 or 70 seats are sold; the extra ten tickets are mostly profit. A hospital is the same kind of business: the doctors, nurses and equipment in the new wings are already on the cost base, so each extra occupied bed earns a high share of its revenue as EBITDA. That is {term('operating leverage', 'When a large share of costs are fixed, so profit rises faster than revenue as volume grows.')}, and it is why a long idea on a hospital usually rests on occupancy.

One chain, then one valuation line. Occupied bed-days rise from 6.79 lakh to 7.88 lakh. Revenue rises by Rs 547.5 crore. With half of it falling through, EBITDA rises from about Rs 747 crore to Rs 1,021 crore, up 37%. At the same 20x, and Rs 1,000 crore of net debt, equity value would rise from about Rs 13,936 crore to Rs 19,411 crore, about 39%. Say plainly that holding the multiple is an assumption.

A structured idea names the event that makes others see what you see. Here it is the occupancy figure hospitals disclose each quarter, and the new wings crossing the point where their EBITDA margins match the mature hospitals. If occupancy moves from 62% to 65% and 68% over the next few quarters, the market can follow the thesis in the reported numbers. If it is flat for two quarters, the idea is not working and the pitch should say that is when you would cut it.

The risk is that the beds fill with patients who pay less. New wings are often filled with insurance-panel and government-scheme patients at lower tariffs. If occupancy reaches 72% but ARPOB falls 5% across the hospital, the extra EBITDA falls from about Rs 274 crore to about Rs 90 crore, because a price cut on existing beds comes straight off EBITDA while the new volume only brings half of its revenue through. Volume falling short is gentler: at 67% occupancy the gain is simply halved, to about Rs 137 crore.

Close the pitch in the order a portfolio manager wants it: thesis in one sentence, the Rs 274 crore number, the quarterly catalyst, the ARPOB risk and what you would watch to know you are wrong, which is ARPOB in the new wings against the mature hospitals.